Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (A.D.E.P.T.) Trial for Oropharynx Malignancy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary)
- Indications Oropharyngeal cancer
- Focus Therapeutic Use
- Acronyms ADEPT
- 25 Nov 2020 Biomarkers information updated
- 05 Oct 2013 New source identified and integrated (Mayo Clinic; 12-010177).
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.